ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,823Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 6645

$1.86M Total Retail Price of All Prescriptions

Rank: 95 out of 6645

765 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 765 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

23% of this provider’s 765 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 26,985 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
WARFARIN SODIUM 1,742 1,636 1 16
HYDROCODONE-ACETAMINOPHEN 1,050 808 S3 2 5
OMEPRAZOLE 1,010 899 3 6
METOPROLOL TARTRATE 984 874 4 13
LEVOTHYROXINE SODIUM 967 834 5 4
LISINOPRIL 881 773 6 3
SIMVASTATIN 834 712 7 1
FUROSEMIDE 741 691 8 11
PANTOPRAZOLE SODIUM 560 471 9 29
AMLODIPINE BESYLATE 538 497 10 2
METFORMIN HCL 517 418 11 7
LANTUS 510 444 12 50
DONEPEZIL HCL 464 446 13 27
GABAPENTIN 417 324 14 18
FAMOTIDINE 398 304 15 33
MIRTAZAPINE 374 340 16 70
NOVOLOG 354 310 17 144
DIVALPROEX SODIUM 346 265 18 113
RISPERIDONE 342 294 19 93
QUETIAPINE FUMARATE 315 232 20 101
HUMALOG 308 254 21 137
NAMENDA 298 298 22 41
POTASSIUM CHLORIDE 293 276 23 28
CARVEDILOL 264 224 24 25
ADVAIR DISKUS 249 219 25 45
ZOLPIDEM TARTRATE 237 184 26 17
BACLOFEN 233 139 27 100
ENOXAPARIN SODIUM 230 224 28 238
ATORVASTATIN CALCIUM 229 174 29 10
ESCITALOPRAM OXALATE 225 182 30 86
OLANZAPINE 223 196 31 140
TRAZODONE HCL 209 191 32 60
LEVOFLOXACIN 207 192 33 83
ABILIFY 206 172 34 204
ATENOLOL 195 163 35 8
PAROXETINE HCL 192 174 36 72
NITROFURANTOIN MONO-MACRO 190 173 37 233
TAMSULOSIN HCL 190 177 37 22
CLOPIDOGREL 186 173 39 36
OXYCODONE-ACETAMINOPHEN 172 86 S2 40 150
BENZTROPINE MESYLATE 170 79 R 41 188
ALENDRONATE SODIUM 169 152 42 14
LEVETIRACETAM 166 110 43 119
HEPARIN SODIUM 166 117 43 248
TRAMADOL HCL 164 141 45 30
DIGOXIN 160 160 46 59
CLONIDINE HCL 159 144 47 56
CITALOPRAM HBR 159 138 47 35
SEROQUEL 158 119 49 208
FLUOXETINE HCL 154 116 50 63
EXELON 153 153 51 149
CARBIDOPA-LEVODOPA 153 152 51 116
TRIAMCINOLONE ACETONIDE 148 120 53 55
CYMBALTA 145 128 54 78
MORPHINE SULFATE ER 144 120 S2 55 124
PRAVASTATIN SODIUM 144 136 55 20
SERTRALINE HCL 143 91 57 43
PHENYTOIN SODIUM EXTENDED 140 112 58 172
PLAVIX 137 121 59 49
FENTANYL 136 123 S2 60 141
NYSTATIN 136 127 60 234
SPIRIVA 134 114 62 65
IPRATROPIUM-ALBUTEROL 125 122 63 201
OXYCONTIN 118 99 S2 64 236
BENAZEPRIL HCL 117 113 65 21
KLOR-CON 10 117 101 65 145
HYDROCHLOROTHIAZIDE 117 101 65 9
LOVASTATIN 114 104 68 15
ALBUTEROL SULFATE 114 99 68 112
GENERLAC 107 79 70 310
SANTYL 106 104 71 302
METOPROLOL SUCCINATE 106 89 71 24
LOSARTAN POTASSIUM 105 93 73 12
SULFAMETHOXAZOLE-TRIMETHOPRIM 103 87 74 134
VENTOLIN HFA 101 77 75 146
AMITRIPTYLINE HCL 100 55 R 76 117
AMIODARONE HCL 100 87 76 160
DIOVAN 100 100 76 19
FINASTERIDE 96 94 79 73
NOVOLIN R 95 95 80 142
MORPHINE SULFATE 89 76 S2 81 326
NYSTOP 88 68 82 348
KLOR-CON 8 86 69 83 123
ALLOPURINOL 85 72 84 31
TRAVATAN Z 84 84 85 342
KLOR-CON M20 83 74 86 203
HYDRALAZINE HCL 80 75 87 77
DIVALPROEX SODIUM ER 80 47 87 273
ISOSORBIDE MONONITRATE ER 80 73 87 66
OXYCODONE HCL 79 73 S2 90 162
FLUOCINONIDE 79 67 90 130
LIDODERM 78 64 92 53
OXYBUTYNIN CHLORIDE ER 77 66 93 179
CEFTRIAXONE 77 74 93 409
PERMETHRIN 76 70 95 384
COMBIVENT 76 72 95 174
SODIUM CHLORIDE 73 67 97 216
MEGESTROL ACETATE 72 62 R 98 104
VALPROIC ACID 72 45 98 285
OXYBUTYNIN CHLORIDE 71 60 100 129
PROPRANOLOL HCL 71 42 100 151
CLOBETASOL PROPIONATE 71 65 100 228
SPIRONOLACTONE 69 69 103 85
KLOR-CON M10 69 69 103 276
ENALAPRIL MALEATE 68 57 105 75
PREDNISONE 68 56 105 57
ACTOS 68 60 105 71
GLIPIZIDE 68 64 105 23
DEMECLOCYCLINE HCL 65 65 10 109 686
DILTIAZEM HCL 65 65 109 351
ACTONEL 64 58 111 92
PROAIR HFA 63 58 112 32
DILANTIN 62 54 113 436
HYDROXYZINE HCL 62 53 R 113 161
ZIPRASIDONE HCL 62 22 113 550
OLANZAPINE ODT 60 53 116 526
LANTUS SOLOSTAR 59 31 117 139
NOVOLOG FLEXPEN 59 22 117 316
ENDOCET 58 45 S2 119 453
HALOPERIDOL 57 0 120 303
FLUTICASONE PROPIONATE 57 51 120 26
LIPITOR 57 41 120 69
DETROL LA 56 44 123 260
SEROQUEL XR 56 22 123 343
LEXAPRO 55 40 125 218
GEMFIBROZIL 54 30 126 96
HYDROMORPHONE HCL 54 54 S2 126 235
PRIMAXIN 54 53 10 126 728
CEPHALEXIN 53 43 129 111
SINGULAIR 52 41 130 76
METHADONE HCL 52 17 S2 130 186
LYRICA 51 43 132 127
METOCLOPRAMIDE HCL 51 45 132 120
OXYCODONE HCL-ACETAMINOPHEN 51 51 S2 132 213
POLYETHYLENE GLYCOL 3350 50 31 135 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.